ferrous ascorbate
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT01160198)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
- Mol. weight
- 406.08 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707305 ↗
Also known as
- ascofer
- ferrous ascorbate
- ferrous ascorbate
- ferrous ascorbate
- ferrous ascorbate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01160198 | Phase 3 | Oct 1, 2010 | GlaxoSmithKline |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2010 |
1 organizations
Page 1 / 1